TN tumours were significantly associated with a poorer 5-year rate of OS (56.9%; 95% CI: [45.3; 66.9] vs. 84.0%; 95% CI: [77.6; 88.7]; p < 0.0001) compared to HR+ and/or HER2+ tumours. This evidence concerns the gene ERBB2 and neoplasm.